alternative-therapies.com PubMed The interstitial cystitis pilot lacks a randomized control arm, is underpowered for robust efficacy conclusions and primarily signals feasibility and short term tolerability
As GLP-1R agonists mediate their appetite-reducing effects within the central nervous system, the trafficking phenotype of exendin-phe1 could result in reduced brain penetration, mitigating against presumed advantageous effects on neuronal GLP-1R desensitization
If you have not lost at least 5% of your weight after 12 weeks on the full dose, your doctor may stop the treatment
Ingredients Active Agents: BPC-157 (Pentadecapeptide) 10mg, TB-500 (Thymosin Beta-4 Analog) 10mg, GHK-Cu (Copper Tripeptide-1) 50mg Format: Sterile Lyophilized Powder (requires reconstitution) Ratio: Synergistic Research Blend (Total Concentration: 70mg per vial) Purity: 99% (HPLC Verified for all components)
They may also increase the body's antioxidant defenses
Sleep deeper & release serotonin